Omnicell (OMCL) Revenue & Revenue Breakdown
Omnicell Revenue Highlights
Latest Revenue (Y)
$1.11B
Latest Revenue (Q)
$290.56M
Main Segment (Y)
Connected Devices, Software Licenses, And Other
Main Geography (Y)
UNITED STATES
Omnicell Revenue by Period
Omnicell Revenue by Year
| Date | Revenue | Change | 
|---|---|---|
| 2024-12-31 | $1.11B | -3.04% | 
| 2023-12-31 | $1.15B | -11.48% | 
| 2022-12-31 | $1.30B | 14.48% | 
| 2021-12-31 | $1.13B | 26.88% | 
| 2020-12-31 | $892.21M | -0.54% | 
| 2019-12-31 | $897.03M | 13.94% | 
| 2018-12-31 | $787.31M | 9.93% | 
| 2017-12-31 | $716.16M | 3.40% | 
| 2016-12-31 | $692.62M | 42.94% | 
| 2015-12-31 | $484.56M | 9.90% | 
| 2014-12-31 | $440.90M | 15.85% | 
| 2013-12-31 | $380.58M | 21.19% | 
| 2012-12-31 | $314.03M | 27.90% | 
| 2011-12-31 | $245.53M | 10.40% | 
| 2010-12-31 | $222.41M | 4.19% | 
| 2009-12-31 | $213.46M | -15.25% | 
| 2008-12-31 | $251.87M | 18.20% | 
| 2007-12-31 | $213.08M | 37.73% | 
| 2006-12-31 | $154.71M | 27.31% | 
| 2005-12-31 | $121.52M | -1.95% | 
| 2004-12-31 | $123.94M | 21.36% | 
| 2003-12-31 | $102.13M | 16.46% | 
| 2002-12-31 | $87.69M | 0.91% | 
| 2001-12-31 | $86.90M | 29.00% | 
| 2000-12-31 | $67.36M | - | 
Omnicell generated $1.11B in revenue during NA 2024, up -3.04% compared to the previous quarter, and up 123.99% compared to the same period a year ago.
Omnicell Revenue by Quarter
| Date | Revenue | Change | 
|---|---|---|
| 2025-06-30 | $290.56M | 7.75% | 
| 2025-03-31 | $269.67M | -12.13% | 
| 2024-12-31 | $306.88M | 8.66% | 
| 2024-09-30 | $282.42M | 2.03% | 
| 2024-06-30 | $276.79M | 12.45% | 
| 2024-03-31 | $246.15M | -4.90% | 
| 2023-12-31 | $258.85M | -13.33% | 
| 2023-09-30 | $298.66M | -0.10% | 
| 2023-06-30 | $298.97M | 2.87% | 
| 2023-03-31 | $290.63M | -2.37% | 
| 2022-12-31 | $297.67M | -14.48% | 
| 2022-09-30 | $348.06M | 5.03% | 
| 2022-06-30 | $331.39M | 3.94% | 
| 2022-03-31 | $318.83M | 2.51% | 
| 2021-12-31 | $311.03M | 4.94% | 
| 2021-09-30 | $296.40M | 8.68% | 
| 2021-06-30 | $272.74M | 8.30% | 
| 2021-03-31 | $251.84M | 1.06% | 
| 2020-12-31 | $249.20M | 16.61% | 
| 2020-09-30 | $213.70M | 7.05% | 
| 2020-06-30 | $199.62M | -13.09% | 
| 2020-03-31 | $229.69M | -7.49% | 
| 2019-12-31 | $248.29M | 8.52% | 
| 2019-09-30 | $228.81M | 5.24% | 
| 2019-06-30 | $217.41M | 7.36% | 
| 2019-03-31 | $202.52M | -4.36% | 
| 2018-12-31 | $211.75M | 3.66% | 
| 2018-09-30 | $204.27M | 8.27% | 
| 2018-06-30 | $188.67M | 3.32% | 
| 2018-03-31 | $182.62M | -7.74% | 
| 2017-12-31 | $197.94M | 5.98% | 
| 2017-09-30 | $186.78M | 3.26% | 
| 2017-06-30 | $180.88M | 20.15% | 
| 2017-03-31 | $150.55M | -12.46% | 
| 2016-12-31 | $171.97M | -2.69% | 
| 2016-09-30 | $176.74M | 2.22% | 
| 2016-06-30 | $172.91M | 1.11% | 
| 2016-03-31 | $171.00M | 31.22% | 
| 2015-12-31 | $130.32M | 4.06% | 
| 2015-09-30 | $125.23M | 11.03% | 
| 2015-06-30 | $112.79M | -2.95% | 
| 2015-03-31 | $116.22M | -4.38% | 
| 2014-12-31 | $121.54M | 8.00% | 
| 2014-09-30 | $112.54M | 7.13% | 
| 2014-06-30 | $105.05M | 3.23% | 
| 2014-03-31 | $101.76M | -3.77% | 
| 2013-12-31 | $105.75M | 12.45% | 
| 2013-09-30 | $94.04M | 0.38% | 
| 2013-06-30 | $93.69M | 7.55% | 
| 2013-03-31 | $87.11M | -3.39% | 
| 2012-12-31 | $90.17M | 6.92% | 
| 2012-09-30 | $84.33M | 11.87% | 
| 2012-06-30 | $75.38M | 17.52% | 
| 2012-03-31 | $64.14M | 1.93% | 
| 2011-12-31 | $62.93M | -2.34% | 
| 2011-09-30 | $64.44M | 5.63% | 
| 2011-06-30 | $61.01M | 6.73% | 
| 2011-03-31 | $57.16M | -0.19% | 
| 2010-12-31 | $57.27M | 1.74% | 
| 2010-09-30 | $56.29M | 2.91% | 
| 2010-06-30 | $54.69M | 0.98% | 
| 2010-03-31 | $54.16M | -0.90% | 
| 2009-12-31 | $54.65M | 1.29% | 
| 2009-09-30 | $53.96M | 2.50% | 
| 2009-06-30 | $52.64M | 0.84% | 
| 2009-03-31 | $52.20M | -15.87% | 
| 2008-12-31 | $62.05M | -3.56% | 
| 2008-09-30 | $64.34M | 1.53% | 
| 2008-06-30 | $63.37M | 2.07% | 
| 2008-03-31 | $62.09M | 7.15% | 
| 2007-12-31 | $57.95M | - | 
Omnicell generated $290.56M in revenue during Q2 2025, up 7.75% compared to the previous quarter, and up 118.04% compared to the same period a year ago.
Omnicell Revenue Breakdown
Omnicell Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | 
|---|---|---|---|---|---|
| Technical Services | $238.21M | $225.83M | $206.69M | $206.99M | $202.38M | 
| Connected Devices, Software Licenses, And Other | $539.17M | $623.58M | $827.92M | $739.07M | $560.37M | 
| Consumables | $91.34M | $84.98M | $75.31M | $73.44M | $75.66M | 
| Hardware And Software | - | - | - | $112.52M | $53.79M | 
Omnicell's latest annual revenue breakdown by segment (product or service), as of Dec 24: Connected Devices, Software Licenses, And Other (62.06%), Technical Services (27.42%), and Consumables (10.51%).
Quarterly Revenue by Product
| Product/Service | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | 
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Consumables | $24.55M | $25.09M | $46.42M | $22.69M | $22.23M | $22.25M | $21.20M | $20.96M | $20.57M | $19.18M | $20.15M | $18.17M | $17.80M | $19.01M | $18.15M | $17.87M | $18.41M | $130.05M | $18.06M | - | 
| Hardware And Software | $63.62M | $63.12M | $47.58M | $44.28M | $43.78M | $36.86M | $28.90M | $23.90M | $22.86M | $116.92M | - | - | - | - | - | - | - | - | - | - | 
| Technical Services | $63.77M | $61.38M | $120.11M | $59.58M | $58.52M | $57.98M | $57.30M | $57.19M | $53.36M | $50.30M | $53.91M | $53.30M | $49.17M | $50.67M | $53.53M | $51.93M | $50.86M | - | - | - | 
| Connected Devices, Software Licenses, And Other | $138.62M | $120.08M | $292.43M | $135.67M | $111.07M | $123.40M | $167.56M | $167.47M | $165.15M | $177.79M | $226.41M | $215.63M | $208.08M | $204.49M | $195.82M | $179.04M | $159.72M | - | - | - | 
| Product | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $175.68M | $151.34M | $138.94M | 
| Service | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $73.52M | - | - | 
| Software-As-A-Service, Subscripition Software, And Technology-Enabled Services | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $16.84M | - | 
| Product and Service, Other | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $4.45M | $3.96M | 
Omnicell's latest quarterly revenue breakdown by segment (product or service), as of Jun 25: Connected Devices, Software Licenses, And Other (47.71%), Technical Services (21.95%), Hardware And Software (21.90%), and Consumables (8.45%).
Omnicell Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | 
|---|---|---|---|---|---|
| UNITED STATES | $1.01B | $1.01B | $1.17B | $1.02B | $797.60M | 
| Non-US | $99.86M | $135.73M | $127.75M | $111.23M | $94.61M | 
Omnicell's latest annual revenue breakdown by geography, as of Dec 24: UNITED STATES (91.02%), and Non-US (8.98%).
Quarterly Revenue by Country
| Country | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | 
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| UNITED STATES | $263.45M | $249.26M | $536.02M | $258.18M | $218.18M | $225.59M | $272.65M | $257.20M | $255.94M | $269.93M | $315.75M | $294.94M | $287.58M | $282.38M | $271.28M | $242.86M | $224.28M | $218.18M | $193.64M | $178.05M | 
| Non-US | $27.12M | $20.40M | $47.65M | $24.24M | $27.98M | $33.26M | $26.01M | $41.77M | $34.69M | $27.74M | $32.30M | $36.45M | $31.25M | $28.66M | $25.13M | $29.88M | $27.57M | $31.02M | $20.06M | $21.57M | 
Omnicell's latest quarterly revenue breakdown by geography, as of Jun 25: UNITED STATES (90.67%), and Non-US (9.33%).
Omnicell Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue | 
|---|---|---|---|
| TDOC | Teladoc Health | $2.57B | $631.90M | 
| ASTH | Astrana Health | $2.03B | $620.39M | 
| CLOV | Clover Health Investments | $1.37B | $477.62M | 
| CNMD | CONMED | $1.31B | $342.35M | 
| OMCL | Omnicell | $1.11B | $290.56M | 
| GDRX | GoodRx | $792.32M | $202.97M | 
| TXG | 10x Genomics | $610.78M | $154.88M | 
| USPH | U.S. Physical Therapy | $560.55M | $164.18M | 
| PHR | Phreesia | $419.81M | $117.25M | 
| SDGR | Schrödinger | $207.54M | $59.55M | 
| OMDA | Omada Health | $169.80M | $54.96M |